V1RG11 activators comprise a chemical class designed to modulate the activity of the V1RG11 protein, a member of the G protein-coupled receptor (GPCR) family. This diverse group includes various molecules that can enhance the natural function of V1RG11 through different mechanisms within the GPCR signaling pathways. The molecules in this chemical class can either directly interact with the receptor to increase its activity or indirectly influence the receptor's function by altering the interaction between the receptor and its G protein or by modulating the downstream signaling effectors. For instance, certain activators can increase the intracellular concentration of second messengers like cyclic adenosine monophosphate (cAMP), a common messenger in GPCR signaling, thus amplifying the receptor's signal. Others can inhibit the breakdown of these second messengers, sustaining the signal for a longer period. Additionally, some molecules can affect the G proteins themselves, either by activating them or by preventing their deactivation, thereby extending the active phase of signal transduction.
The activation of V1RG11 by these molecules relies on the intricate balance of the receptor's signaling environment. Some activators work by shifting the equilibrium towards an active state of the receptor or by sustaining the signaling once it has been initiated. This can be achieved by modulating the receptor's ability to bind its endogenous ligand or by changing the conformation of the receptor to an active state. On the other hand, certain activators can influence the receptor indirectly. They can act on other proteins within the GPCR pathway, such as enzymes that generate or degrade second messengers, or on proteins that regulate the receptor's sensitivity to its ligand. By doing so, they modulate the receptor's signaling capacity. The diverse mechanisms by which these activators operate reflect the complexity of GPCR signaling and the multiple points at which modulation can occur to enhance the activity of V1RG11.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that prevents the breakdown of cAMP, thereby amplifying GPCR signaling pathways that involve cAMP as a secondary messenger, could possibly activate V1RG11. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inactivates Gi/o type G proteins, which can lead to the enhancement of GPCRs that are negatively regulated by these proteins, could possibly activate V1RG11 if it is Gi/o-coupled. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Direct activator of protein kinase C (PKC), which can modulate GPCR signaling by phosphorylating the receptor or associated proteins, could possibly activate V1RG11. | ||||||
Carbachol | 51-83-2 | sc-202092 sc-202092A sc-202092C sc-202092D sc-202092B sc-202092E | 1 g 10 g 25 g 50 g 100 g 250 g | $122.00 $281.00 $388.00 $683.00 $1428.00 $3060.00 | 12 | |
A cholinergic agonist that can activate muscarinic GPCRs leading to the activation of downstream pathways, could possibly activate V1RG11 through signaling pathway crosstalk. | ||||||
KI 8751 | 228559-41-9 | sc-203090 | 5 mg | $142.00 | 2 | |
A specific inhibitor of Gq proteins, which can alter the signaling of GPCRs coupled to Gq proteins; this could possibly activate V1RG11 through changes in cellular signaling balance. | ||||||